Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 2471627, 7 pages
https://doi.org/10.1155/2017/2471627
Research Article

Antitumor Effect of KML-B-Treated Dendritic Cells via Induction of Lymphocyte Activation

1Singapore Bioimaging Consortium, Agency for Science, Technology and Research, 11 Biopolis Way, No. 02-02 Helios, Singapore 138667
2Department of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon 540-950, Republic of Korea
3Mistle Biotech Co. Ltd, Pohang 37668, Republic of Korea
4Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Republic of Korea
5Suncheon Research Center for Natural Medicines, Suncheon, Republic of Korea

Correspondence should be addressed to Sung-Tae Yee; rk.ca.nohcnus@eatgnus

Received 11 November 2016; Revised 6 February 2017; Accepted 5 March 2017; Published 29 May 2017

Academic Editor: Ramon Kaneno

Copyright © 2017 Jong-Jin Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Urruticoechea, R. Alemany, J. Balart, A. Villanueva, F. Viñals, and G. Capellá, “Recent advances in cancer therapy: an overview,” Current Pharmaceutical Design, vol. 16, no. 1, pp. 3–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. O. J. Finn, “Immuno-oncology: understanding the function and dysfunction of the immune system in cancer,” Annals of Oncology, vol. 23, Supplement 8, pp. viii6–viii9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Pinzon-Charry, T. Maxwell, and J. A. López, “Dendritic cell dysfunction in cancer: a mechanism for immunosuppression,” Immunology and Cell Biology, vol. 83, no. 5, pp. 451–461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. L. Shiao, A. P. Ganesan, H. S. Rugo, and L. M. Coussens, “Immune microenvironments in solid tumors: new targets for therapy,” Genes & Development, vol. 25, no. 24, pp. 2559–2572, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Palucka and J. Banchereau, “Cancer immunotherapy via dendritic cells,” Nature Reviews Cancer, vol. 12, no. 4, pp. 265–277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kaczanowska, A. M. Joseph, and E. Davila, “TLR agonists: our best frenemy in cancer immunotherapy,” Journal of Leukocyte Biology, vol. 93, no. 6, pp. 847–863, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. Kim, Y. H. Hwang, K. Y. Kang et al., “Enhanced dendritic cell maturation by the B-chain of Korean mistletoe lectin (KML-B), a novel TLR4 agonist,” International Immunopharmacology, vol. 21, no. 2, pp. 309–319, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. I. D. Jung, S. K. Jeong, C. M. Lee et al., “Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist,” Cancer Research, vol. 71, no. 8, pp. 2858–2870, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Gao, Y. Sun, S. Chen et al., “Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice,” Vaccine, vol. 31, no. 18, pp. 2273–2280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. R. Teixeira, K. A. Cavassani, R. B. Gomes et al., “Potential of KM+ lectin in immunization against Leishmania amazonensis infection,” Vaccine, vol. 24, no. 15, pp. 3001–3008, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Y. Sung, E. B. Byun, D. S. Song et al., “Effect of gamma irradiation on mistletoe (Viscum album) lectin-mediated toxicity and immunomodulatory activity,” Federation of European Biochemical Societies Open bio, vol. 3, no. 1, pp. 106–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Y. Lyu and W. B. Park, “Effects of Korean mistletoe lectin (Viscum album coloratum) on proliferation and cytokine expression in human peripheral blood mononuclear cells and T-lymphocytes,” Archives of Pharmacal Research, vol. 30, no. 10, pp. 1252–1264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Souza, F. C. Carvalho, L. P. Ruas, R. Ricci-Azevedo, and M. C. Roque-Barreira, “The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties,” Glycoconjugate Journal, vol. 30, no. 7, pp. 641–657, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. J. Park, J. H. Hong, H. J. Kwon et al., “TLR4-mediated activation of mouse macrophages by Korean mistletoe lectin-C (KML-C),” Biochemical and Biophysical Research Communications, vol. 396, no. 3, pp. 721–725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. B. Kang, Y. C. Yoo, K. H. Lee, H. S. Yoon, E. Her, and S. K. Song, “Korean mistletoe lectin (KMLIIU) and its subchains induce nitric oxide (NO) production in murine macrophage cells,” Journal of Biomedical Science, vol. 15, no. 2, pp. 197–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. M. Her, H. S. An, K. D. Kim et al., “Immunoadjuvant activity of Korean mistletoe lectin B-chain,” Korean Journal of Pharmacognosy, vol. 42, no. 3, pp. 246–252, 2011. View at Google Scholar
  17. T. L. Whiteside, “Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention,” Seminars in Cancer Biology, vol. 16, no. 1, pp. 3–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. J. Kim and H. Cantor, “CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful,” Cancer Immunology Research, vol. 2, no. 8, pp. 91–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. K. L. Knutson and M. L. Disis, “Tumor antigen-specific T helper cells in cancer immunity and immunotherapy,” Cancer Immunology, Immunotherapy, vol. 54, no. 8, pp. 721–728, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Ikeda, L. J. Old, and R. D. Schreiber, “The roles of IFN gamma in protection against tumor development and cancer immunoediting,” Cytokine & Growth Factor Reviews, vol. 13, no. 2, pp. 95–109, 2002. View at Publisher · View at Google Scholar · View at Scopus